Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study.
- 2008-03
- RCT · n = 59
- The American Journal of Clinical Nutrition 87(3)
- F. Dépeint
- G. Tzortzis
- J. Vulevic
- K. I’Anson
- G. Gibson
- PubMed: 18326619
- DOI: 10.1093/AJCN/87.3.785
- High evidence
- Highly Cited
Addition of the novel galactooligosaccharide mixture significantly increased the bifidobacterial population ratio compared with the placebo (P < 0.05), whereas 7 g/d of the novel galactooligosaccharide significantly increased the bifidobacterial ratio compared with the commercial galactooligosaccharide (P < 0.05).
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes